T4-monotherapy
-
Discordance in thyroid symptoms reported by patients and their doctors
There’s no surprise that patients and doctors would disagree about the incidence rate of hypothyroid symptoms in a given patient. “We have an average of 7.2 symptoms per patient” says the cohort of 262 patients. “No, you have an average of 4.0 symptoms per patient,” says the cohort of 100 doctors about those 262 patients.…
-
Thyroid patient blaming and shaming, part 3: Advocacy and Science
In this Part 3, I continue my rebuttal of a research article that blames thyroid patients for causing harm to themselves by making requests of doctors for tests and therapies. In this post, I explain the good signs that thyroid patients’ self-advocacy is sometimes effective and is making a difference.
-
Caution: Doctors perform T3-ectomies without our consent
We all know a “thyroidectomy” is the surgical removal of a thyroid gland. Nobody removes a vital gland without a patient’s informed consent. If your medical system and doctor are ethical, you as a patient have the opportunity to weigh the risks and benefits of the procedure and give signed consent. We need to consider…
-
The TSH-T3 disjoint in thyroid therapy
There’s a deep lie behind today’s TSH-based definition of “euthyroid” status and today’s policies of TSH normalization in therapy. The lie is that the loss of the thyroid and the initiation of thyroid hormone dosing has NOT altered and skewed natural TSH-FT3-FT4 hormone relationships. Yes, thyroid disease and therapy DO alter and skew these functional…
-
How to calculate LT3 vs. LT4 substitution: New thyroid science
What does NEW thyroid science have to say on the topic of thyroid pharmaceutical equivalency? How many micrograms of L-T3 Liothyronine (i.e. Cytomel) are equivalent to L-T4 Levothyroxine (i.e. Synthroid)? Thyroid hormone pharmaceutical monographs currently provide very rigid and low-ratio equivalency statements: In my previous post, I uncovered the historical origins of this low 25:100…